Viewing Study NCT00127933


Ignite Creation Date: 2025-12-25 @ 2:42 AM
Ignite Modification Date: 2026-02-20 @ 4:29 PM
Study NCT ID: NCT00127933
Status: COMPLETED
Last Update Posted: 2011-08-10
First Post: 2005-08-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer
Sponsor: Hoffmann-La Roche
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords: